skip navigation

There is a known problem with the Find@UNC button on Google Scholar until Thursday, November 27th. See workaround

Rachael Posey, MSLS; Liaison to the School of Pharmacy: Home

Office Hours

Rachael will be holding office hours every Wednesday at noon in the PharMart and every Thursday at noon in Beard 114. Personalized help is also available by appointment for both online and in-person consultations. Call or email to schedule an appointment.

Introduction

Bio

Rachael is the Liaison to the School of Pharmacy. Before coming to the HSL, she worked in systematic review creation, with experience in resource management, study selection, report creation, and editing, first at the Duke University Evidence-based Practice Center, then at the RTI-UNC Evidence-based Practice Center. Her research interests include evidence-based practice, comparative effectiveness, and systematic review searching and creation.

Education

BA, English, Duke University
MSLS, School of Information and Library Science, University of North Carolina - Chapel Hill

Recent Publications

Peer Reviewed Publications

Jones WS, Schmit KM, Vemulapalli S, Subherwal S, Patel MR, Hasselblad V, Heidenfelder BL, Chobot MM, Posey R, Wing L, Sanders GD, Dolor RJ. Treatment Strategies for Patients With Peripheral Artery Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. Available from http://www.ncbi.nlm.nih.gov/books/NBK148574/

McCrory DC, Coeytaux RR, Schmit KM, Kraft B, Kosinski AS, Mingo AM, Vann LM, Gilstrap DL, Hargett CW, Lugogo NL, Heidenfelder BL,Posey R, Irvine RJ, Wing L, Pendergast K, Dolor RJ. Pulmonary Arterial Hypertension: Screening, Management, and Treatment [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK143034/

Williams JW, Cox CE, Hargett CW, Gilstrap DL, Castillo CE, Govert JA, Lugogo NL, Coeytaux RR, McCrory DC, Hasselblad V, McBroom AJ, Posey R, Gray R, Sanders GD. Noninvasive Positive-Pressure Ventilation (NPPV) for Acute Respiratory Failure [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jul. Available from http://www.ncbi.nlm.nih.gov/books/NBK99179/

Powers BJ, Crowley MJ, McCrory DC, Pendergast K, Posey R, Hadley C, Gray R, Sanders GD. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension: Identification of Future Research Needs From Comparative Effectiveness Review No. 34 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. Available from http://www.ncbi.nlm.nih.gov/books/NBK84673/

Other Publications

Feltner C, Wines R, Simon J, Rowe C, Posey R, Jonas D. Newer Diabetes Medications and Combinations: Streamlined Update 1 Report. Final original report. Prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University. Portland, OR. 2014. 

Posey R, Wines R, Feltner C. Drug Class Review: Second Generation Antidepressants: Preliminary Scan Report #2. Prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University. Portland, OR. 2014. 

Posey R, Wines R, Feltner C. Drug Class Review: Alzheimer’s Drugs: Preliminary Scan Report #4. Prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University. Portland, OR. 2013. 

Posey R, Wines R, Feltner C. Drug Class Review: Controller Medications for Asthma: Preliminary Scan Report #1. Prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University. Portland, OR. 2013. 

Posey R, Wines R, Feltner C. Drug Class Review: Targeted Immune Modulators: Preliminary Scan Report #1. Prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University. Portland, OR. 2013. 

Feltner C, Wines R, Posey R, Jonas D. Newer Diabetes Medications, TZDs, and Combinations: Single Drug Addendum: Linagliptin. Final original report. Prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University. Portland, OR. 2012.